• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素与体外循环——并非一概而论。

Antibiotics and extracorporeal circulation--one size does not fit all.

作者信息

Gonçalves-Pereira João, Oliveira Bruno

出版信息

Crit Care. 2014 Dec 19;18(6):695. doi: 10.1186/s13054-014-0695-6.

DOI:10.1186/s13054-014-0695-6
PMID:25673035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4331389/
Abstract

Dosing of antibiotics in critically ill patients is a significant challenge. The increasing number of patients undergoing extracorporeal membrane oxygenation further complicates the issue due to inflammatory activation and to drug sequestration in the circuit. Since patients receiving extracorporeal membrane oxygenation commonly face severe infections, appropriate antibiotic selection and correct dosing is of paramount importance to improve survival. Therapeutic drug monitoring (whenever available) or population pharmacokinetics, based on readily available clinical and laboratory data, should help tailor antibiotic dosing to the individual patient.

摘要

在重症患者中使用抗生素进行给药是一项重大挑战。由于炎症激活以及回路中的药物隔离,接受体外膜肺氧合的患者数量不断增加,这使得该问题更加复杂。由于接受体外膜肺氧合的患者通常面临严重感染,因此选择合适的抗生素并正确给药对于提高生存率至关重要。治疗药物监测(如有条件)或基于现成的临床和实验室数据的群体药代动力学,应有助于根据个体患者情况调整抗生素给药方案。

相似文献

1
Antibiotics and extracorporeal circulation--one size does not fit all.抗生素与体外循环——并非一概而论。
Crit Care. 2014 Dec 19;18(6):695. doi: 10.1186/s13054-014-0695-6.
2
Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge.美罗培南在体外膜肺氧合患者中的治疗:一个持续存在的药代动力学挑战。
Crit Care. 2015 Jun 22;19(1):263. doi: 10.1186/s13054-015-0953-2.
3
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.体外膜肺氧合与肾脏替代治疗对美罗培南药代动力学的联合影响:一项匹配队列研究。
Crit Care. 2014 Dec 12;18(6):565. doi: 10.1186/s13054-014-0565-2.
4
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的患者的药代动力学变化。
J Crit Care. 2012 Dec;27(6):741.e9-18. doi: 10.1016/j.jcrc.2012.02.013. Epub 2012 Apr 18.
5
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.改善 ICU 特殊情况下的抗生素剂量:烧伤、肾脏替代治疗和体外膜氧合。
Curr Opin Crit Care. 2012 Oct;18(5):460-71. doi: 10.1097/MCC.0b013e32835685ad.
6
Therapeutic drug monitoring for meropenem after the extracorporeal membrane oxygenation circuit change in children: is it necessary?儿童体外膜肺氧合回路更换后美罗培南的治疗药物监测:有必要吗?
Minerva Anestesiol. 2016 Sep;82(9):1018-9. Epub 2016 Apr 20.
7
Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?体外膜肺氧合期间抗生素药代动力学的改变:值得关注吗?
J Antimicrob Chemother. 2013 Mar;68(3):726-7. doi: 10.1093/jac/dks435. Epub 2012 Oct 30.
8
β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.β-内酰胺类药物在体外膜肺氧合治疗期间的药代动力学:一项病例对照研究。
Int J Antimicrob Agents. 2015 Mar;45(3):278-82. doi: 10.1016/j.ijantimicag.2014.11.005. Epub 2014 Dec 8.
9
The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.肾脏替代治疗方案中的变异性对危重症患者哌拉西林、美罗培南和万古霉素药物清除率的影响:文献分析和剂量方案*。
Crit Care Med. 2014 Jul;42(7):1640-50. doi: 10.1097/CCM.0000000000000317.
10
Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?体外膜肺氧合期间的抗生素给药:系统重要吗?
Curr Opin Anaesthesiol. 2020 Feb;33(1):71-82. doi: 10.1097/ACO.0000000000000810.

引用本文的文献

1
β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity.重症患者的β-内酰胺类药物给药:关于最佳疗效以及预防耐药性和毒性的叙述性综述
Antibiotics (Basel). 2022 Dec 18;11(12):1839. doi: 10.3390/antibiotics11121839.
2
Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock.加拿大重症监护学会临床实践指南:血管加压素和血管加压素类似物在分布性休克危重症成人中的应用。
Can J Anaesth. 2020 Mar;67(3):369-376. doi: 10.1007/s12630-019-01546-x. Epub 2019 Dec 3.
3
[Clinical pharmacokinetics of anti-infective drugs in extracorporeal membrane oxygenation].[体外膜肺氧合中抗感染药物的临床药代动力学]
Anaesthesist. 2019 Dec;68(12):821-826. doi: 10.1007/s00101-019-00702-8.
4
Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge.美罗培南在体外膜肺氧合患者中的治疗:一个持续存在的药代动力学挑战。
Crit Care. 2015 Jun 22;19(1):263. doi: 10.1186/s13054-015-0953-2.

本文引用的文献

1
The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.体外膜肺氧合与肾脏替代治疗对美罗培南药代动力学的联合影响:一项匹配队列研究。
Crit Care. 2014 Dec 12;18(6):565. doi: 10.1186/s13054-014-0565-2.
2
Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011.从2006年到2011年,美国成人体外膜肺氧合的使用量增长了433%。
ASAIO J. 2015 Jan-Feb;61(1):31-6. doi: 10.1097/MAT.0000000000000160.
3
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.危重症患者经验性使用β-内酰胺类抗生素治疗时目标未达到的危险因素。
Intensive Care Med. 2014 Sep;40(9):1340-51. doi: 10.1007/s00134-014-3403-8. Epub 2014 Jul 23.
4
β-lactam antibiotic concentrations during continuous renal replacement therapy.连续性肾脏替代治疗期间β-内酰胺类抗生素的浓度
Crit Care. 2014 May 22;18(3):R105. doi: 10.1186/cc13886.
5
Dose modulation: a new concept of antibiotic therapy in the critically ill patient?剂量调整:危重症患者抗生素治疗的新概念?
J Crit Care. 2013 Aug;28(4):341-6. doi: 10.1016/j.jcrc.2012.11.018. Epub 2013 Jan 18.
6
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO.ASAP ECMO:体外膜肺氧合期间抗生素、镇静剂和镇痛药药代动力学:一项优化 ECMO 期间药物治疗的多中心研究。
BMC Anesthesiol. 2012 Nov 28;12:29. doi: 10.1186/1471-2253-12-29.
7
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation.回路中药物的隔离可能导致体外膜肺氧合期间的治疗失败。
Crit Care. 2012 Oct 15;16(5):R194. doi: 10.1186/cc11679.
8
Augmented renal clearance in septic patients and implications for vancomycin optimisation.脓毒症患者的增强肾清除率及其对万古霉素优化的影响。
Int J Antimicrob Agents. 2012 May;39(5):420-3. doi: 10.1016/j.ijantimicag.2011.12.011. Epub 2012 Mar 3.
9
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams.危重症患者中的抗生素:β-内酰胺类药物药代动力学的系统评价。
Crit Care. 2011;15(5):R206. doi: 10.1186/cc10441. Epub 2011 Sep 13.
10
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.危重症患者β-内酰胺类药物的治疗药物监测:概念验证。
Int J Antimicrob Agents. 2010 Oct;36(4):332-9. doi: 10.1016/j.ijantimicag.2010.06.008. Epub 2010 Aug 3.